Hypolipidemic drugs and diabetes mellitus

Abstract

Diabetes mellitus associates with high cardiovascular risk. The absolute values of cardiovascular risk tend to be even higher than as calculated from the SCORE tables.

Recent randomized clinical trials have shown evidence of benefit and safety of more intensive LDL-cholesterol lowering in patients with diabetes and established cardiovascular disease supporting guidelines for a more intensive LDL goal of therapy.

Keywords

• diabetes mellitus type 2
• dyslipidaemia
• hypolipidemic treatment
• cardiovascular risk
• atherosclerosis